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ABSTRACT
rescription drug abuse is a major health problem 
1globally.  Various drugs, such as analgesics, Pcough syrups, vitamin preparations and 
laxatives among others are being used by individuals 
for reasons other than the medical indications. The 
abuse of opioid analgesics such as pentazocine is a 
2growing public health problem worldwide.  
Pentazocine is a kappa opioid receptor agonist that is 
widely used for pain relief. Intramuscular injection of 
pentazocine has been associated with various 
complications, including skin ulcers, skin abscesses 
3,4and abnormal skin pigmentation.  Fibrous myopathy 
5,6has also been reported by some authors.  In Nigeria, 
the abuse of pentazocine is under-reported and there is 
paucity of  reports  on the cutaneous and 
musculoskeletal complications of parental pentazocine 
abuse. We report a case of multiple gluteal abscesses 
and extensive fibrosis of the gluteal muscles caused by 
parental pentazocine abuse.
CASE SUMMARY
Mrs. M.S, a 39 year old housewife presented to us on the 
st1  of July, 2015 with three weeks history of swelling on 
the left buttock. She was in apparent good health until 
she developed progressive painful swelling on the 
lateral aspect of the left gluteal region. There was 
associated fever and generalized body weakness. She 
was not a known diabetic or sickle cell anemia patient 
but had been treated for pulmonary tuberculosis twice 
in 2000 and 2008 respectively.
On examination at presentation, she was chronically 
ill-looking, pale, afebrile and anicteric. Her pulse rate 
was 90 beats per minute and blood pressure was 
100/60mmHg. She was in obvious painful distress and 
had difficulty in sitting down on account of pain in the 
left buttock.
Examination of the musculoskeletal system revealed a 
mass on the left gluteal region measuring 5x6cm, firm 
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surgery were similar to those on the left buttock, except 
for multiple discharging sinuses (figure 2). She had an 
uneventful surgical drainage and debridement with 
approximately 200ml of pus drained (figure 3). The 
wounds healed after 6 weeks. She is presently being 
managed by the psychiatrist.
DISCUSSION
Reports on incidence and complications of pentazocine 
abuse in our environment are scanty. Cutaneous 
complications of pentazocine injections have been 
4, 7, 8 described in few case reports. These complications 
include deep, punched out ulcers, fibrous plaques, 
3, 4, 7, 8 sinuses and hyper pigmentation. Other rarely 
reported complications of pentazocine injection are 
9 deep vein thrombosis, toxic epidermal necrolysis,  
10 11fibromyositis and contracture  and gluteal abscesses.
Our report highlights the fact that pentazocine abuse is 
an important public health problem in our 
environment. It also reveals that pentazocine injection 
abuse can present with atypical gluteal abscesses and 
extensive myofibrosis. The gluteal abscesses most 
likely were caused by the inoculation of the site with 
bacteria from the syringe or needle or due to poor site 
preparation during self injections. This may also 
explain the bacteria culture of Staphylococcus aureus 
which is a common skin commensal. The exact 
mechanism of the myofibrosis is not clearly 
understood. However, it has been suggested that 
pentazocine is most soluble in acidic conditions and 
may get precipitated in the slightly alkaline pH of the 
extracellular fluid, which may then initiate a chronic 
3inflammatory response.
Some authors have suggested that hormone sensitive 
lipase present in normal adipose tissue, when 
stimulated locally by pentazocine may lead to break 
12down of fat and subsequent inflammatory reaction.
Often times, the recognition of pentazocine abuse in 
clinical practice is difficult. The patients often conceal 
the use of this drug and merely present to hospital for 
symptomatic treatment of the complications. This may 
pose a diagnostic challenge particularly in atypical 
cases where the more common causes of these 
complications have been excluded. This was the case in 
our index patient who had atypical gluteal abscesses 
with skin and soft tissue changes. A high index of 
suspicion is therefore required. Clinicians should 
always consider the possibility of pentazocine abuse in 
the presence of atypical skin and soft tissue 
complications such as ulcers, sinuses and abscesses. 
This is particularly important when they occur in the 
gluteal region or thighs which are common sites of 
intramuscular injections. 
and tender with differential warmth. There was severe 
wasting of the gluteal muscles on both sides, worse on 
the left (figure 1). No neurological deficit was noted. 
There were healed scars and sinuses and hyper 
pigmented skin changes on both gluteal regions. A 
diagnostic needle aspiration was done which yielded 
pus. A diagnosis of left gluteal abscess was made. Her 
full blood count result showed: PCV = 18%, WBC = 
312.8x10 / uL, N = 69%, L = 29%, E = 2%, ESR = 
st65mm/1 hr. C-reactive protein assay was not done. 
Retroviral screening was negative. Her urinalysis and 
fast blood glucose tests were normal. Screening for 
tuberculosis was negative. Pelvic x-ray revealed no 
bony involvement. However, chest x-ray showed 
consolidation of the left mid and lower lung zones. 
Microscopy and culture of the aspirate yielded 
moderate growth of Staphylococcus aureus. She 
received three units of blood and was commenced on 
intravenous ceftriaxone according to the sensitivity 
pattern, which was changed to augmentin tablets after 
5 days.  Surgical drainage was done and 250ml of pus 
was drained. Intra-operative findings included 
leathery thick skin that was adherent to the underlying 
tissues. There was also extensive fibrosis of the gluteal 
muscles habouring pockets of pus with necrotic tissues. 
The pus was drained and all necrotic tissues were 
excised. Tissue biopsy showed acellular myofibrosis 
with chronic inflammation. Fungal and mycobacterial 
cultures of tissue specimen were negative. The wound 
continued to drain purulent exudate despite antibiotics 
administration and wound dressing for about 60 days, 
which was rather unusual. This prompted further 
enquiries that revealed that patient had been abusing 
pentazocine injection. She received pentazocine 
injections regularly for 3 weeks while on hospital 
admission in 2008 for treatment of pulmonary 
tuberculosis for pain relief and subsequently 
developed dependence to the drug. After discharge, 
she started self injection of the drug due to the euphoric 
effect. The injections were procured without 
prescription from neighboring pharmacy shops. She 
initially took two intramuscular injections daily but 
presently injected herself with 6 ampoules of 
pentazocine injections daily. Her preferred site of the 
injection was the buttocks. She denied abuse of other 
drugs. The patient was referred to the clinical 
psychologist and psychiatrist for counseling and 
management. She was subsequently discharged home 
following complete wound healing.
However, 3 weeks after discharge, she was readmitted 
with swelling and multiple discharging sinuses on the 
right buttock. While undergoing counseling by the 
psychiatry team, she developed withdrawal symptoms 
of restless, anxiety and intense craving for the drug and 
subsequently had a relapse. Findings on clinical and at 
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Our patient had free access to pentazocine even though 
it is a precipitation drug and this encouraged the abuse 
of the drug. The prolonged discharge of pus from the 
sinuses may be explained by the fact that pus and 
necrotic tissues were trapped within the fibrotic 
muscles thus making it difficult to drain easily and 
inaccessible to antibiotics. Prolonged antibiotics 
administration is therefore recommended for such 
atypical abscesses.
CONCLUSION                                          
This report highlights important musculoskeletal 
complications of parenteral pentazocine abuse. It also 
underscores the significance of the precaution that 
should be taken while prescribing pentazocine as a 
routine painkiller. Pentazocine abuse should be 
considered a differential diagnosis in cases multiple 
and recurrent gluteal abscesses especially when there 
are associated skin and soft tissue changes. Finally, 
legislation against indiscriminate use of control drugs 
should be enforced.
We noted that confidence building with such patients 
can help to unravel the etiology of these complications 
and furthermore help to build a therapeutic alliance to 
wean the patients off the drug and maintain abstinence. 
It was also observed that our patient received injection 
pentazocine for up to 3 weeks while on admission in a 
hospital for treatment of pulmonary tuberculosis. This 
most likely predisposed the patient to drug 
dependence. It is therefore pertinent for clinicians to 
acquaint themselves with the WHO guidelines for 
management of chronic pain in order to avoid the 
dangers of drug dependence in patients with chronic 
pain. The abuse of pentazocine is being increasingly 
9 13reported across the globe  including Nigeria.  With 
free over the counter access to this drug in Nigeria and 
many developing countries, the awareness of these 
complications is important so that unwanted sides 
effects can be avoided. There should be a stricter 
enforcement of laws guiding the use precipitation 
drugs in Nigeria. This will help in controlling the abuse 
of these drugs and its complications.
Figure 1 showing left gluteal atrophy and right gluteal 
abscess (arrow) and discharging sinuses
Figure 2 showing right gluteal abscess 
communicating with the sinus 
Figure 3 showing drainage of right gluteal abscess
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